COVID Symptoms: What the Research Shows About the Most Common Signs, Timing, and Recovery
Table of Contents
Key Takeaways
- In Omicron-era studies, typical COVID symptoms were cold-like, with sore throat, runny nose and fever prominent.[1][2] In the ZOE study, loss of smell fell from 52.7% of cases in the Delta period to 16.7% in the Omicron period.[1]
- In my clinical experience, COVID can rarely be told apart from other viral infections by symptoms alone; loss of smell no longer points specifically to COVID, and a drop in oxygen saturation is not specific to it either.
- Symptoms often start within a few days of exposure (mean 3.42 days for Omicron), and about a third of Omicron infections had no symptoms at the time of testing.[3][4]
- Rapid antigen tests are most sensitive in the first week of symptoms; in one cohort, two tests 48 hours apart reached 93.4% sensitivity in symptomatic people.[5][6]
- In my experience of everyday Finnish practice, COVID is no longer tested routinely, but in some patients with a high fever, a four-pathogen sample (SARS-CoV-2, influenza A and B, RSV) can help streamline diagnostics when the result may affect care.
- In my practice, the key question is often whether a bacterial complication – most often sinusitis, ear infection or pneumonia – has developed, rather than which virus caused the illness.
- Among those who lose smell or taste, most recover within months.[7] In my clinical experience, some patients still have prolonged fatigue and exhaustion that can be difficult to treat.
- In athletes, heart involvement after COVID was uncommon (0.7% in a registry of 3,018, using that study’s diagnostic criteria).[8] In a selected subgroup of athletes with exertional chest pain who underwent cardiac MRI, 5 of 24 had probable or definite cardiac involvement.[9]
Studies from the Omicron period showed that the classic early-pandemic picture of COVID-19 – fever, a persistent cough, and a sudden loss of smell – became less representative of infections. In a UK community study of more than 1.5 million adults, cold-like symptoms such as runny nose, sore throat, sneezing and hoarse voice were selected as predictors of infection only for Omicron, while loss of smell or taste became relatively less predictive.[2]
As a physician and former competitive athlete, I look at COVID symptoms from two angles: what they mean for an ordinary patient deciding whether to test or stay home, and what they mean for someone who wants to get back to training safely. This article covers the most common COVID symptoms, how the symptom profile has shifted between variants, when symptoms typically start, how reliable home tests are, how long symptoms last, and the specific warning signs that matter for athletes.
When COVID-19 first reached Finnish healthcare in 2020, it arrived abruptly. Restrictions were broad, and the Uusimaa region was isolated from the rest of the country; working emergency shifts, I crossed the Uusimaa border many times. Many emergency departments ran a mandatory infection clinic with separate “dirty” and “clean” sides, a large share of elective appointments was cancelled, and in practice the whole health system revolved around the pandemic. In my clinical experience, many patients lost contact with their ongoing care during that period, and in my view we are still largely living in the aftermath.
The Most Common COVID Symptoms Today
Some of the largest datasets on COVID symptoms come from the Omicron period. In the ZOE COVID Study, researchers compared 4,990 vaccinated, symptomatic adults infected while Omicron was dominant with an equal, matched group infected during Delta dominance. Sore throat was reported by 70.5% of the Omicron-period group versus 60.8% of the Delta-period group.[1]
The REACT-1 study, which sampled the population of England at random, adds important detail. Among people who tested positive, the share reporting at least one of 26 listed symptoms was 75.9% with Omicron BA.2, 70.0% with BA.1, 63.8% with Delta, 54.7% with Alpha and 45.0% with the original strain.[2] For both Omicron sublineages, fever had the strongest association of any single symptom with a positive test.[2]
In REACT-1, all 26 surveyed symptoms were positively associated with testing positive, and cold-like and influenza-like symptoms became relatively more predictive in the Omicron period. Symptoms reported in these Omicron-period studies include:[1][2]
- Sore throat and hoarse voice
- Runny or blocked nose and sneezing
- Fever and chills
- Cough
- Headache, muscle aches and fatigue
- Loss or change of smell or taste (less common than with earlier variants, but still meaningful when present)
In my clinical experience, patients most often present with a cough with mucus, a sore throat and a varying degree of fever. Some also have sinus or ear symptoms, or a runny nose. The severity varies a great deal between patients: for some, COVID is only a mild cold that settles on its own, while for others it is a severe illness that may cause fever or keep them in bed for several days.
REACT-1 also found that fever, chills and sore throat were the symptoms most strongly linked to a higher viral load – each associated with roughly a tenfold increase. The authors interpreted this to mean that in the Omicron period these and other influenza-like and cold-like symptoms were the ones most likely to indicate higher viral load and increased infectiousness.[2]
One caveat: these large symptom studies were done in 2020–2022, and they may not fully reflect the variants circulating today. The REACT-1 authors themselves stressed that symptom profiles keep shifting and need ongoing monitoring.[2]
How COVID Symptoms Changed: Loss of Smell vs Sore Throat
Loss of smell was once the symptom most strongly linked with a positive test.[2] In the ZOE comparison, it was reported by 52.7% of people infected during the Delta period but by only 16.7% during the Omicron period.[1] Hospital admission was also less common in the Omicron period among these vaccinated participants (1.9% vs 2.6%).[1]
REACT-1 showed the same pattern from a different angle. For the original strain, Alpha and Delta, a change or loss of smell or taste had the strongest link with testing positive; for Omicron, influenza-like and cold-like symptoms became relatively more predictive.[2]
This shift was just as visible at the bedside. Early in the pandemic, some patients were very ill: I remember patients arriving at hospital with an oxygen saturation of 60%, close to life-threatening, and on many COVID wards patients died or were transferred to intensive care. For others, even then, it was little more than an ordinary flu. Fortunately, the illness has since calmed down, and in some of the patients I see today COVID resembles a normal cold.
Many patients still ask me whether their illness could be COVID. In my clinical experience, the honest answer is often that it may be, but it can no longer necessarily be told from the outside, because many other viral infections can cause exactly the same symptoms. Earlier, findings such as a drop in oxygen saturation or loss of smell raised a strong suspicion of COVID; today, in my experience, there is no clear clinical hallmark that would reliably set it apart.
Milder on average does not mean trivial. Compared with BA.1, BA.2 infection was associated with more reported symptoms and a greater likelihood of people saying their symptoms affected daily activities “a lot.”[2]
When Do COVID Symptoms Start? The Incubation Period
A 2022 meta-analysis in JAMA Network Open pooled 142 studies with 8,112 patients. The overall mean incubation period – time from infection to the first signs or symptoms – was 6.57 days. For Omicron, based on five studies with 829 patients, the mean was 3.42 days (95% CI 2.88–3.96), compared with 4.41 days for Delta.[3]
Two caveats keep this honest. Most included studies came from the early wild-type period, and the authors reported that the differences between variants were not statistically significant in their comparison.[3] Even so, the data suggest that after an exposure, COVID symptoms may often appear within a few days.
COVID Without Symptoms: How Common Is It?
Not everyone infected will notice COVID symptoms at all. A meta-analysis of eight studies covering 7,640 people with confirmed Omicron infection found a pooled asymptomatic proportion of 32.40% (95% CI 25.30–39.51%), with high heterogeneity between studies (I² = 97.7%).[4] The proportion was higher in groups with a median age under 20 years (43.75%).[4]
Note how “asymptomatic” was defined: having no symptoms at the time of testing or diagnosis.[4] The authors note that this group includes both pre-symptomatic and truly asymptomatic infections, so some of these people may have developed symptoms later.[4] Either way, a lack of symptoms today does not rule out infection after an exposure.
Testing When You Have COVID Symptoms
Rapid antigen tests are more sensitive in people with symptoms, especially in the first week of illness, and repeating the test improves detection.
A 2022 Cochrane review, whose main analysis covered 152 studies of single test applications (228 evaluations), found an average sensitivity of 73.0% in symptomatic people versus 54.7% in asymptomatic people. Sensitivity was 80.9% in the first week after symptom onset but fell to 53.8% in the second week. Specificity was high in both groups (99.1% and 99.7%).[5] The review authors note that because sensitivity varies, people who test negative may still be infected.[5]
Repeating the test helps. In a US prospective cohort using home tests, symptomatic participants who tested twice, 48 hours apart, reached an aggregated sensitivity of 93.4% within the first week after their first positive PCR. In asymptomatic participants, three tests at 48-hour intervals reached 79.0% (when isolated single positive PCR results were excluded).[6]
In my experience of everyday practice in Finland, COVID is no longer tested very routinely. Early in the pandemic we tested a lot, but today the overall clinical picture is often more relevant than identifying the exact virus, and if the illness does not otherwise cause concern, testing is easily skipped. In my clinical experience, COVID may therefore often go unnoticed altogether, for example when a mildly ill patient feels the illness will pass with rest. Home antigen tests are available from pharmacies, and in my experience they are relatively affordable, whereas COVID testing in private healthcare can cost considerably more. In mild, uncomplicated illness, a result also rarely changes treatment. The exception is people in risk groups, for whom a positive test can still lead to further measures; I still see nirmatrelvir–ritonavir (Paxlovid) used for some of these patients.
Today COVID is often just one of the many respiratory infections of the cold season, but some patients still have unusually severe symptoms, and a febrile illness can at worst resemble pneumonia. For this reason, in my practice we still often take a so-called four-pathogen sample in selected patients with a high fever, when identifying the pathogen may affect care. The sample covers SARS-CoV-2, influenza A and B, and RSV. In practice, this streamlines diagnostics: if a patient has a high fever but only modest inflammatory markers and a clear chest X-ray, a positive COVID result supports COVID as the cause of the symptoms, although other diagnoses and complications still need to be considered from the overall clinical picture.
How Long Do COVID Symptoms Last?
Two kinds of lingering symptoms deserve particular attention.
Loss of smell and taste
Among people who did lose smell or taste, a 2022 BMJ meta-analysis of 18 studies (3,699 patients) found that 74.1% had recovered their sense of smell by 30 days, 85.8% by 60 days, 90.0% by 90 days and 95.7% by 180 days. For taste the corresponding figures were 78.8%, 87.7%, 90.3% and 98.0%. Modelling suggested that persistent self-reported smell problems may develop in about 5.6% of affected patients, and persistent taste problems in about 4.4%.[7] Women were less likely than men to recover their sense of smell (odds ratio 0.52).[7]
These data come from earlier variants; the authors found no studies reporting recovery by variant.[7]
Long COVID
When COVID symptoms persist for months, the question becomes long COVID. Under the 2024 definition from the US National Academies of Sciences, Engineering, and Medicine (NASEM), long COVID is an infection-associated chronic condition after SARS-CoV-2 infection that lasts at least three months and affects one or more organ systems. A positive COVID test is not required for the diagnosis.[10]
Vaccination before infection is associated with lower risk. A 2023 meta-analysis of observational studies, which defined post-COVID conditions as any symptom present four or more weeks after infection – a broader definition than the NASEM one above – estimated a vaccine effectiveness against post-COVID conditions of 32.0% overall, 36.9% with two doses and 68.7% with three doses received before infection. The stratified analysis did not demonstrate a protective association for vaccination given after infection, although the authors cautioned that one large study accounted for more than 98% of the participants in that analysis.[11] Because these are observational data, they show association rather than proof of cause.
In my clinical experience, some patients still have prolonged COVID symptoms today, most often fatigue and exhaustion. From a clinical perspective, these situations can be very difficult to treat.
COVID Symptoms in Athletes
For athletes, the key questions are how long COVID symptoms keep them out of training and which symptoms signal heart involvement. For a fuller discussion of cardiac risk and return to play, see COVID in Athletes.
Symptoms and time lost from training
In 147 UK international athletes with symptomatic COVID-19 (71 confirmed and 76 probable cases; February 2020 to January 2021), the most common symptoms were fatigue (57%), dry cough (50%) and headache (46%). Median symptom duration was 10 days (IQR 6–17), but 14% had symptoms beyond 28 days. Median time lost from full training and competition was 18 days, and 27% were not fully available more than 28 days after infection.[12]
The type of symptoms mattered. A lower respiratory pattern – shortness of breath, with or without chest pain, cough or fever – was present in 18% and was linked to a higher risk of prolonged symptoms (risk ratio 3.0) and longer time loss (risk ratio 2.1).[12]
Time loss decreased over the period studied. In a later study of UK athletes preparing for international competition, median time loss after COVID-19 fell from 27 days (IQR 13–40) in April–June 2020 to 10 days (IQR 8–13) in October–December 2022.[13]
Heart involvement: rare, but symptoms matter
In the Big Ten COVID-19 Cardiac Registry, 1,597 college athletes underwent cardiac MRI screening after COVID-19, and 37 (2.3%) met criteria for COVID-19 myocarditis – 9 clinical and 28 subclinical. Had testing been based on cardiac symptoms alone, only 5 athletes would have been detected (0.31%).[14]
A larger registry of 3,018 young competitive athletes found definite, probable or possible cardiac involvement, using its diagnostic criteria, in 21 (0.7%), with one adverse cardiac event during follow-up that was likely unrelated to the infection. The authors concluded that the prevalence of cardiac involvement and the risk of clinical events in short-term follow-up were low.[8]
The symptom that stands out is chest pain during exercise. In a cohort of 3,597 collegiate athletes, persistent symptoms beyond three weeks were present in 44 of 3,529 (1.2%) and exertional cardiopulmonary symptoms in 137 of 3,393 (4.0%). Among those with exertional symptoms, 12 of 137 (8.8%) were diagnosed with a COVID-related complication. In a selected subgroup of athletes with exertional chest pain who underwent cardiac MRI, 5 of 24 (20.8%) had probable or definite cardiac involvement.[9]
The overall picture for athletes: cardiac involvement was uncommon in these cohorts,[8] but the ORCCA authors concluded that exertional cardiopulmonary symptoms, specifically chest pain, warrant a comprehensive evaluation.[9] For more on training and illness, see Exercise When Sick and Fever and Training.
Viral or Bacterial? When COVID Symptoms Need Closer Assessment
In my practice, the first question in diagnostics is usually whether the illness is purely viral or whether a bacterial infection is involved. In my clinical experience, a bacterial infection can often cause clearer localised symptoms, such as sinus pain, toothache, ear pain or reduced hearing, and some patients may even feel dizzy. Others may have more troublesome chest symptoms with fever and shortness of breath. In these situations, I often consider it worth ruling out a bacterial complication.
In my practice, the bacterial complication I see most often is sinusitis, followed perhaps by ear infection or pneumonia. I also see eye infections such as conjunctivitis fairly often, although conjunctivitis can also be part of a viral infection itself. When findings like these appear, I often explain to patients that these findings may raise suspicion of a bacterial complication rather than an effect of the COVID virus itself, although a viral infection can sometimes cause similar findings.
Conclusion
In Omicron-era studies, COVID symptoms looked much more like a common cold than the early-pandemic picture. In the ZOE study of vaccinated adults, sore throat was reported by 70.5% of Omicron-period cases, while loss of smell fell from 52.7% to 16.7%.[1] Symptoms often begin a few days after exposure, and around a third of Omicron infections had no symptoms at the time of testing. Rapid antigen tests are most sensitive in the first week of symptoms, and repeating a test after 48 hours improves detection.
In my clinical experience, COVID can no longer reliably be told apart from other viral infections by its symptoms. In practice, the clinical picture often matters more than the exact virus: the key questions are how severe the illness is and whether a bacterial complication, such as sinusitis, ear infection or pneumonia, has developed. For many patients COVID is a mild illness that settles on its own, while some still struggle with prolonged fatigue and exhaustion.
For athletes, heart involvement after COVID was uncommon in large registries,[8] while exertional chest pain was the symptom the ORCCA authors singled out as warranting a comprehensive evaluation.[9]
References
[1] https://doi.org/10.1016/S0140-6736(22)00327-0
[2] https://doi.org/10.1038/s41467-022-34244-2
[3] https://doi.org/10.1001/jamanetworkopen.2022.28008
[4] https://doi.org/10.3390/vaccines10071049
[5] https://doi.org/10.1002/14651858.CD013705.pub3
[6] https://doi.org/10.7326/M23-0385
[7] https://doi.org/10.1136/bmj-2021-069503
[8] https://doi.org/10.1161/CIRCULATIONAHA.121.054824
[9] https://doi.org/10.1136/bjsports-2021-104644
[10] https://doi.org/10.1007/s11606-025-09415-8
[11] https://doi.org/10.1017/ash.2023.447
[12] https://doi.org/10.1136/bjsports-2021-104392
